502  American  Pharmaceutical  Association.  {A™c{°ber590Lm" 
(4)  Standardization  of  essential  oils  as  suggested,  1896. 
(5)  Change  standard  of  linum,  sinapis  alba,  and  sinapis  nigra,  for  reasons 
given  in  report,  1896. 
(6)  Tincture  nux  vomica.  Returning  to  formula  of  1880,  retaining  the 
standard  strength  as  in  the  1890  edition. 
(7)  Standardization  of  podophyllum,  prunus  virginiana,  sanguinaria,  sarsa- 
parilla,  quillaja,  senega,  strophanthus,  1897. 
(8)  The  report  of  1898,  paragraphs  1  to  13  inclusive,  are  especially  referred 
to  the  Committee  on  Revision  for  their  consideration. 
(9)  The  same  report,  referring  to  the  report  of  1896,  on  which  no  action  was 
taken,  viz.:  To  dismiss  all  tinctures  having  a  fluid  extract  of  the  same  drug 
official,  and  all  fluid  extracts  having  a  tincture  of  the  same  drug  official,  and 
substitute  for  such  tinctures  and  fluid  extracts  a  50  per  cent,  tincture  under  dis- 
tinctive title. 
( ro)  Paragraphs  16  and  17  of  the  same  report,  referring  to  spirit  nitrous 
ether  and  crude  carbolic  acid. 
(11)  Report  of  1899,  paragraph  1,  referring  to  present  formula  for  cold 
cream. 
The  officers  of  the  section  for  the  ensuing  year  are:  Chairman, 
Lyman  F.  Kebler  and  Secretary,  Joseph  W.  England.  Mr.  Hall- 
berg  moved  that  the  officers  of  the  section  consider  the  feasibility 
of  either  forming  a  standing  committee  or  having  a  reporter  on 
drug  adulteration  and  drug  market. 
COMMERCIAL  SECTION. 
The  Commercial  Section  held  one  session  on  Tuesday  afternoon. 
The  Chairman,  Charles  A.  Rapelye,  delivered  the  annual  address 
in  which  he  pointed  out  that  this  section  was  originally  "  planned 
to  handle  as  best  it  might  the  ever  present  question  of  cut  prices, 
or  at  least  to  restrict  the  consideration  of  that  question  to  its  proper 
time  and  place  in  the  work  of  the  Association.  It  has  by  the  forma- 
tion of  the  N.A.R.D.  had  that  question  taken  out  of  its  hands, 
leaving  the  section  more  time  to  consider  the  mercantile  interests 
of  pharmacy  which  are  now  forcing  themselves  upon  our  attention 
to  a  much  greater  degree  than  could  have  been  foreseen  at  the 
birth  of  this  section."  He  further  stated  that  "  no  one  will  attempt 
to  deny  that  great  progress  has  been  made  in  professional  phar- 
macy and  it  has  not  been  accomplished  without  constant  study  and 
application,  and  our  treatment  of  the  commercial  problems  that 
surround  us  must  be  upon  the  same  lines.  We  must  not  expect 
that  the  vexed  questions  of  the  trade  will  solve  themselves ;  but,  if 
overcome,  it  must  be  by  untiring  application  to  the  devising  of  ways 
